RTW Investments, LP 13D and 13G filings for Ultragenyx Pharmaceutical Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 06:42 am Sale | 2024-09-30 | 13G | Ultragenyx Pharmaceutical Inc. RARE | RTW Investments, LP | 1,968,002 2.100% | -4,919,084 (-71.42%) | Filing |
| 2024-02-14 07:46 am Purchase | 2023-12-31 | 13G | Ultragenyx Pharmaceutical Inc. RARE | RTW Investments, LP | 6,887,086 8.400% | 2,920,171 (+73.61%) | Filing |
| 2023-02-14 10:10 am Purchase | 2022-12-31 | 13G | Ultragenyx Pharmaceutical Inc. RARE | RTW Investments, LP | 3,966,915 5.700% | 3,966,915 (New Position) | Filing |